MENA/GCC Thoracic Tumor Board — Met NSCLC ALK+ (2026)

Dates:: 2026-04-28
Organizer:: Pfizer & Alfaisal University
Location:: Online via Zoom
Specialty:: Hematology / Oncology
Format:: Online

A regional Thoracic Tumor Board bringing together leading medical oncologists from across MENA, the GCC, Europe, and North America to discuss real-world cases in Metastatic NSCLC ALK+ management. Jointly hosted by Pfizer and Alfaisal University, the session features case-based learning, multidisciplinary panel discussions, and the latest updates on ALK-targeted therapy. Highlights 🎤 12 internatio

Full details and registration

This event has ended

Concluded 5 months ago · Apr 28, 2026

Browse upcoming

MENA/GCC Thoracic Tumor Board — Met NSCLC ALK+ (2026)

1 / 1

1 photos · tap to enlarge

Hematology / Oncology Webinar Online

Apr 28 – Apr 28, 2026

Online · Online via Zoom

MENA/GCC Thoracic Tumor Board — Met NSCLC ALK+ (2026)

Pfizer & Alfaisal University

Listed 24 Apr 2026

Add to Calendar

About this event

A regional Thoracic Tumor Board bringing together leading medical oncologists from across MENA, the GCC, Europe, and North America to discuss real-world cases in Metastatic NSCLC ALK+ management.

Jointly hosted by Pfizer and Alfaisal University, the session features case-based learning, multidisciplinary panel discussions, and the latest updates on ALK-targeted therapy.

Highlights

🎤 12 international expert speakers
🌍 Speakers from KSA, Egypt, Jordan, Kuwait, Germany & Canada
🧬 Focus on Met NSCLC ALK+ case discussions
💊 Pfizer Satellite Symposium: Built to Last — Lorbrena 5-year updates & practical therapy management (Prof. Geoffrey Liu)
🕖 3+ hour multidisciplinary tumor board (7:00 PM – 10:05 PM)

Format

Live interactive webinar — case presentations followed by expert panel discussions and audience Q&A. Cases cover diagnosis, biomarker testing, first-line therapy, sequencing, and resistance management in ALK+ NSCLC.

Registration is free. Register via the official Zoom link below.